Glejak: badanie kliniczne

Gdzie prowadzone jest badanie

Ośrodki prowadzące badanie w Polsce (1), alfabetycznie według miejscowości:

• Department of Neurosurgery of Medical University of Warsaw Rekrutuje
  WarszawaKontakt

Więcej badań w tych miastach:

• Warszawa

Stan rekrutacji pochodzi z rejestrów badań i może się zmienić szybciej, niż zaktualizuje go sponsor. Nasz doradca sprawdzi aktualny stan w wybranym ośrodku. Nie publikujemy nazwisk lekarzy ani ich danych kontaktowych.

Cel badania

Opis z rejestru (w języku angielskim):

The purpose of this study is to compare two commonly used methods of closing the skin after surgery for an intracranial tumor. Skin closure is one of the most important steps in neurosurgical procedures, as it has a major influence on how well the wound heals. In patients with brain tumors, proper wound healing is especially important because it may affect how soon additional treatments, such as radiotherapy or chemotherapy, can be started.

There are different ways to close the skin after surgery, including running sutures and interrupted sutures. Both methods are widely used and considered safe. However, in oncological neurosurgery, there is limited scientific evidence comparing their effects, and the choice of technique is often based on the surgeon's personal experience. In this study, investigators will compare skin closure using running absorbable sutures with interrupted non-absorbable sutures. Investigators will evaluate how well, depending on used suturing methods, the wound heals and how often wound-related complications occur, such as infection, separation of the wound edges, or leakage of cerebrospinal fluid. Investigators believe that the results of this study will help improve wound care in patients undergoing neurosurgical treatment for brain tumors and, as a result, may contribute to better recovery and overall quality of life.

Leczenie w badaniu

Kryteria udziału

Kryteria w języku angielskim, tak jak w rejestrze.

To główne kryteria z rejestru. Pełną listę i ostateczną decyzję o udziale ustala lekarz prowadzący badanie.

Inne badania: glejak

Rekrutuje

Badanie kliniczne

TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)

Miasta: BydgoszczWiek: od 18 latSponsor: Prof. Franciszek Lukaszczyk Memorial Oncology Center

Rekrutuje

Badanie kliniczne

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

Miasta: WarszawaWiek: 18-80 latSponsor: Medical University of Warsaw

RekrutujeObserwacyjne

Badanie obserwacyjne

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Miasta: WarszawaWiek: od 18 latSponsor: Medical University of Warsaw

Rekrutuje

Badanie kliniczne

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

Miasta: WarszawaWiek: 18-80 latSponsor: Medical University of Warsaw

RekrutujeFaza II

Badanie fazy II leku trametinib

Multicenter, open label study using molecularly determined targeted therapies in children 3-18 years of age with DIPG (diffuse intrinsic pontine glioma- DIPG)- DIPGen

Badane leki: trametinib

Miasta: Katowice, WarszawaWiek: do 64 latSponsor: Instytut Pomnik Centrum Zdrowia Dziecka

RekrutujeFaza III

Badanie fazy III leku temozolomide i pembrolizumab

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Badane leki: temozolomidepembrolizumab+4

Miasta: Bydgoszcz, Gliwice, ŁódźWiek: od 18 latSponsor: Novocure GmbH

Wszystkie badania: glejak